# Transvaginal Human Acellular Dermal Matrix for Prolapse Treatment

> **NCT06404931** · PHASE2 · RECRUITING · sponsor: **Hospital Mutua de Terrassa** · enrollment: 90 (estimated)

## Conditions studied

- Prolapse; Female
- Prolapse Genital
- Prolapse Uterovaginal

## Interventions

- **PROCEDURE:** Vaginal hysterectomy plus matrix reinforcement and sacrospinous fixation with Anchorsure® device
- **PROCEDURE:** Vaginal hysterectomy plus anterior colporrhaphy
- **PROCEDURE:** Vaginal hysterectomy plus sacrospinous fixation with Anchorsure® device

## Key facts

- **NCT ID:** NCT06404931
- **Lead sponsor:** Hospital Mutua de Terrassa
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-01
- **Primary completion:** 2025-01-01
- **Final completion:** 2026-01-01
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2025-01-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06404931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06404931, "Transvaginal Human Acellular Dermal Matrix for Prolapse Treatment". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06404931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*